Evidence map›Paper›PMID 41602901›Full record

ArticleFrontiers in pediatrics2025

Isavuconazole as initial antifungal therapy combined with surgical management of pediatric pulmonary mucormycosis: a case report and literature review.

Yao Sun, Lihua Yuan, Tianjiao Hu, Chuan Sun, Dandan Yang, Man Tian, Shichao Dong, Haiyan Gu

Abstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yao SunDepartment of Pharmacy, Children's Hospital of Nanjing Medical University, Nanjing, China.
Lihua YuanDepartment of Pharmacy, Children's Hospital of Nanjing Medical University, Nanjing, China.
Tianjiao HuDepartment of Pharmacy, Children's Hospital of Nanjing Medical University, Nanjing, China.
Chuan SunDepartment of Pharmacy, Children's Hospital of Nanjing Medical University, Nanjing, China.
Dandan YangDepartment of Pharmacy, Children's Hospital of Nanjing Medical University, Nanjing, China.
Man TianDepartment of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, China.
Shichao DongDepartment of Pharmacy, The Second Hospital of Tianjin Medical University, Tianjin, China.
Haiyan GuDepartment of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive mucormycosis (IM) in pediatric patients is a rare but life-threatening fungal disease with limited treatment options. Isavuconazole is a new triazole that has shown efficacy and safety in adults for both primary and salvage treatment of mucormycosis. However, data regarding the initial use of isavuconazole in children are rare. In this study, we report a case of a 6-year-old girl with diabetes mellitus. Metagenomic next-generation sequencing detected

Indexed as

diabetesinitial treatmentisavuconazolemucormycosispediatric

Identifiers

PMID41602901
PMCPMC12832280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.